The action of guinea pig serum in bringing about in vivo, the regression of 3 transplanted mouse and rat lymphomas was first described by Kidd in papers from this laboratory in 1953 (1, 2). Several highly specific features were shown: first, that inhibition was produced only by guinea pig serum, sera from other animal species being completely devoid of effect. Secondly, susceptibility to the effects of guinea pig serum was found to be sharply confined to certain tumor cell lines. Thus, although 3 lymphomas were found initially to be sensitive to guinea pig serum, 14 other tumor cell lines of similar morphology were not inhibited in subsequent tests. Since this time, however, a number of additional cell lines of widely differing histological types, notably the Walker carcinosarcoma, the rat fibrosarcoma ACMCA2, and recently 10 different newly induced mouse lymphomas, have been shown to be guinea pig serum-sensitive (3-5). Thirdly, although guinea pig serum proved highly effective in ~ivo against tumor cells of sensitive lines, particularly lymphomas 6C3HED and A2, it produced no sign of toxicity in the hosts and furthermore proved innocuous for Lymphoma 6C3HED cells when held in contact with them in vitro during several hours at 37°C.The experiments pedormed at this time, however, did not make it possible to determine which of the constituents of guinea pig serum were responsible for the antllymphoma effects. In this paper the question has been examined further, using ceils of Lymphonm 6C3HED, and in a companion paper observations are reported which throw light on a particular character of these neoplastic cells that may determine their susceptibility to the effects of guinea pig serum in vivo.